Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial
Katherine Karakoula1, Thomas S Jacques2, Kim P Phipps3
1Brain Tumour Research Centre, School of Applied Sciences, University of Wolverhampton, Wolverhampton WV1 1LY, UK.
Abstract:
Promoter hypermethylation and transcriptional silencing is a common epigenetic mechanism of gene inactivation in cancer. To identify targets of epigenetic silencing in paediatric intracranial ependymoma, we used a pharmacological unmasking approach through treatment of 3 ependymoma short-term cell cultures with the demethylating agent 5-Aza-2'-deoxycytidine followed by global expression microarray analysis. We identified 55 candidate epigenetically silenced genes, which are involved in the regulation of apoptosis, Wnt signalling, p53 and cell differentiation. The methylation status of 26 of these genes was further determined by combined bisulfite restriction analysis (COBRA) and genomic sequencing in a cohort of 40 ependymoma samples. The most frequently methylated genes were BEX1 (27/40 cases), BAI2 (20/40), CCND2 (18/40), and CDKN2A (14/40). A high correlation between promoter hypermethylation and decreased gene expression levels was established by real-time quantitative PCR, suggesting the involvement of these genes in ependymoma tumourigenesis. Furthermore, ectopic expression of brain-expressed X-linked 1 (BEX1) in paediatric ependymoma short-term cell cultures significantly suppressed cell proliferation and colony formation. These data suggest that promoter hypermethylation contributes to silencing of target genes in paediatric intracranial ependymoma. Epigenetic inactivation of BEX1 supports its role as a candidate tumour suppressor gene in intracranial ependymoma, and a potential target for novel therapies for ependymoma in children.
Insights
Epigenetic silencing of genes through promoter hypermethylation is common in paediatric intracranial ependymoma. Brain-expressed X-linked 1 (BEX1) was found to be epigenetically inactivated, acting as a tumor suppressor.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Promoter hypermethylation and transcriptional silencing are key epigenetic mechanisms for gene inactivation in cancer.
- Understanding these mechanisms in paediatric intracranial ependymoma is crucial for identifying therapeutic targets.
Purpose of the Study:
- To identify epigenetically silenced genes in paediatric intracranial ependymoma.
- To investigate the role of these silenced genes in tumourigenesis.
- To evaluate the therapeutic potential of targeting these genes.
Main Methods:
- Pharmacological unmasking using 5-Aza-2'-deoxycytidine on ependymoma cell cultures.
- Global expression microarray analysis to identify candidate silenced genes.
- Combined bisulfite restriction analysis (COBRA), genomic sequencing, and real-time quantitative PCR to validate methylation and expression levels.
- Ectopic expression of BEX1 to assess its functional role.
Main Results:
- Identified 55 candidate epigenetically silenced genes involved in apoptosis, Wnt signalling, p53, and cell differentiation.
- BEX1, BAI2, CCND2, and CDKN2A were the most frequently methylated genes.
- Demonstrated a strong correlation between promoter hypermethylation and decreased gene expression.
- Ectopic expression of BEX1 significantly inhibited ependymoma cell proliferation and colony formation.
Conclusions:
- Promoter hypermethylation contributes to target gene silencing in paediatric intracranial ependymoma.
- Epigenetic inactivation of BEX1 suggests its role as a tumour suppressor gene.
- BEX1 represents a potential therapeutic target for childhood ependymoma.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


